متاآنالیز شیوع مصرف سیگار در جمعیت ایران by دکتر محمود موسی‌زاده1، دکتر حسن ضیاءالدینی2، دکتر علی میرزازاده3, & احد اشرفی عسگرآباد4، دکتر علی اکبر حق‌دوست5,
1- PhD Student, Research Center for Modeling in Health, Institute for Futures Studies in Health, Kerman University of Medical 
Sciences, Kerman, Iran 
2- Associate Professor, Neuroscience Research Center, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran 
3- Kerman Physiology Research Center, Kerman University of Medical Sciences, Kerman, Iran 
4- Instructor, Department of Epidemiology, Bam University of Medical Sciences, Kerman, Iran 
5- Professor, Regional Knowledge Hub for HIV/AIDS Surveillance, WHO Collaborating Center AND School of Public Health, 
Kerman University of Medical Sciences, Kerman, Iran 
Correspondence to: Ali Akbar Haghdoost PhD, Email: ahaghdoost@gmail.com 
  
140 Addict Health, Summer & Autumn 2013; Vol 5, No 3-4 
 
http://ahj.kmu.ac.ir,    7 October 
Meta-analysis of Smoking Prevalence in Iran 
Mahmood Moosazadeh MPH1, Hassan Ziaaddini MD2, Ali Mirzazadeh PhD3, 
Ahad Ashrafi-Asgarabad MSc4, Ali Akbar Haghdoost PhD5 
 
Abstract 
Background: There are numerous studies and documents regarding the prevalence of smoking in Iran. Thus, 
to provide suitable information for decision-making and policy-making in this regard, the prevalence of 
smoking in Iran was evaluated using the meta-analysis of the results of the existing researches. 
Methods: Data were collected by searching the keywords cigarette, smoking, tobacco, and nicotine in English 
databases, searching their Persian equivalents in Persian Databases, and in non-electronic resources. After 
studying the titles and texts of collected articles, the repeated and irrelevant cases were excluded. Cases 
which had the inclusion criteria of this meta-analysis were entered into the Stata software. According to 
heterogeneity results, random effect model was used to estimate the prevalence of smoking. 
Findings: In initial studies and non-communicable surveillance system, 274992 Iranian adults were studied 
regarding daily smoking. Among initial studies, smoking prevalence varied from 12.3% to 38.5% in men, and 
from 0.6% to 9.8% in women. Based on the meta-analysis of initial studies and risk factors of 
non-communicable disease surveillance system, smoking prevalence was estimated 21.7% and 19.8% in men 
and 3.6% and 0.94% in women, respectively. Moreover, smoking prevalence in all subjects was estimated 
13.9% according to the meta-analysis of the initial study. 
Conclusion: The findings of this meta-analysis revealed that a significant part of the general population over 
15 years of age, and one fifth of Iranian male adults smoke. Thus, concerning causal relationship confirmed 
between smoking and most diseases, if suitable guidelines are not employed the diseases related to this factor 
will increase in Iran. 
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Introduction 
Consuming narcotics is one of the main causes of 
preventable premature mortality throughout the 
world. It plays an important role in the global 
burden of the diseases. Cigarette smoking has a 
causal relationship with many diseases including 
oral, throat, lung, laryngeal, esophageal, bladder, 
kidney, pancreatic, cervical, and liver cancers.1-4 In 
a 50-year study, it was concluded that non-smokers 
live ten years more than smokers.5 According to 
existing scientific documents, not only is cigarette 
smoking bad for smokers, but also it is harmful for 
other people who are close to them.6 
Cigarettes are significant risks factor for public 
health. Presenting numbers and figures of the 
prevalence of this risk factor in every society is an 
action which can play an important role in the 
making of policies and decisions to improve 
public health. Accordingly, numerous studies 
have been carried out in this regard all over the 
world. By reporting these results, we can present 
the capacity of this problem for the related 
authorities. For example in a report, the 
prevalence of smoking in Jordan, Pakistan, Qatar, 
and Saudi Arabia was 30%, 23%, 25%, and 20%, 
respectively. The same report showed that the 
prevalence of smoking was 12% in Iran.7 
Initial electronic search and researchers' 
experience show that numerous studies have been 
conducted in the form of primary study or 
national projects (risk factors of non-
communicable disease surveillance system) in 
different parts of Iran regarding prevalence of 
smoking. These studies have presented different 
levels of smoking prevalence. In a research in 
1999, smoking prevalence for the Iranian 
population was 11.9%.8 In a study carried out by 
Emami et al., 10.6% of adults were active smokers 
(they smoked every day).9 One of the studies 
conducted in recent years showed that 14% of 
people in Iran use narcotics; men smoke 6 times 
more than women. Similarly, it was shown that 
smoking prevalence in Ilam, Yazd, Golestan, 
Sistan and Baloichestan, and Boushehr Provinces 
were 7.6%, 8.6%, 9.1%, 20.3%, and 21.2%, 
respectively.10 
Presenting different results of smoking in the 
Iranian population causes all researchers, health 
authorities, and other organizations and 
enterprises to use various numbers and figures 
based on the accessibility of information and their 
preference. Thus, health authorities doubt which 
results and studies to trust in their preventive 
programs. One of the most important research 
methods which help us gain an accurate 
estimation of the prevalence of a factor in society 
is a meta-analysis and structured review. 
Although meta-analysis was just used, in the past, 
in clinical work-measuring studies, it is now used 
to combine results of descriptive-analytical 
studies for various phenomena including different 
aspects of smoking by different researchers.11,12 
No meta-analysis has been done to combine 
results of the prevalence of smoking in the general 
population of Iran. Therefore, researchers decided 
to present a reliable evaluation of the prevalence 
of smoking. This was done through extracting and 
collecting all available reports, documents, and 
studies using structured review methods, 
combining their results using meta-analysis, and 
by taking into consideration their limitations and 
the heterogeneity between them. In this case, 
evidence-based decision makings will be 
provided for programming and policy making. 
Methods 
The present research is a meta-analysis and a 
systematic review to determine the prevalence of 
smoking among Iranian adults. Document review 
method was used in this research. 
 
Research strategy 
In this research, to find studies published 
electronically between 21/03/2001 and 
21/07/2012, articles published in foreign and 
domestic journals and theses available in Persian 
databases of "SID, Iranmedex, Magiran, Medlib, 
and Irondoc" and English databases of "Pubmed, 
Google Scholar, and World Health Organization 
(WHO) Site" were used. In this search strategy, 
Persian and English keywords and probable 
combination of keywords, main, and important 
words were used. The main keywords included 
cigarette, smoking, narcotics, tobacco, nicotine, 
Iran/Iranian, names of provinces of Iran, and 
operators "and" and "or" and their Persian 
equivalents. Search was done between 
21/07/2012 and 24/07/2012. Moreover, the 
reference list of these studies was reviewed for 
more sensitivity and selection of more studies. 
Research evaluation was done randomly by one  
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of the researchers; no study was excluded. 
To have access to results of the first step of 
non-communicable surveillance system in Iran, 
paper reports of these studies published in 2007, 
2008, and 2009 were used. To have access to 
findings of studies carried out in 2004 and 2006 
which were not available electronically, 
information related to the care system of non-
contagious disease risk factor were used. 
 
Description of studies of risk factor of non-
communicable disease surveillance system in Iran  
This study has been carried out since 2004 
according to the recommendations of the World 
Health Organization to achieve valid and 
comparable data in national and international 
levels.13 Its first phase finished in 2009 (five 
reviews in 2004, 2006, 2007, 2008, and 2009). It was 
a periodic study which used questionnaires. 
Samples were selected for the first time in all 
provinces of Iran using information available in 
databases of Post Coding and Geographical 
General Office of the Islamic Republic of Iran Post 
Company through a systematic approach and a 
multi-step cluster sampling method. In this study, 
sampling was done equally for men and women 
in the five age groups of 15-24, 25-34, 35-44, 45-54, 
and 55-64. In describing different statuses of 
smoking, the methods proposed by WHO were 
used; a person who smoked at least one cigarette 
a day (7 cigarettes a week) at the time of the study 
was considered an active smoker.14 
 
Study selection 
The full text or summary of all articles, 
documents, and reports obtained from our 
research were extracted. After studying titles, 
repeated items were excluded. It is worth 
mentioning that to avoid republication of results 
of studies of non-communicable surveillance 
system, findings were examined by researchers to 
recognize and exclude repeated studies. Then, 
articles were carefully studied by researchers and 
the relevant articles were selected and the 
irrelevant ones were excluded. 
 
Quality evaluation 
After the relevant studies were determined in 
terms of title and content, STROBE checklist 
content was reviewed.15 Questions which covered 
different aspects of methodology including 
determining suitable sample volume, sampling 
method, statistical universe, variable measuring 
methods, data collection tools, description of 
smoking criterion, statistical analysis, study 
geographic area, research objectives, suitable 
presentation of findings, and presentation of 
results based on objectives were determined to 
evaluate the quality of documents. Every question 
had one score. Every article which obtained at 
least 8 scores could enter meta-analysis.  
 
Data extraction 
Data was extracted by researchers in terms of 
article title, corresponding author, research year, 
total sample volume, sample volume in terms of 
gender, research place, smoking prevalence index, 
prevalence of smoking in terms of gender, age 
group, number of cigarettes smoked a day, and 
smoking criterion of study population. Then, data 
were entered into Excel program. 
 
Study inclusion criteria 
After the evaluation process and obtaining 
necessary scores, all Persian and English studies 
which had determined the prevalence of smoking 
in Iranian adults were selected.  
 
Study exclusion criteria 
After the initial research, irrelevant studies were 
excluded after their titles, abstracts, and full texts 
were studied. The quality of the remaining articles 
was evaluated using a checklist; those that 
achieved scores less than eight were also excluded. 
 
Analysis 
To analyze data, Stata Statistical Software (version 
11; Stata Corporation, College Station, TX, USA) 
was used. Standard error of prevalence of 
smoking was calculated in every study according 
to the binomial distribution formula. Finally, 
Cochran's test was used to determine the 
heterogeneity index among studies. According to 
heterogeneity results (with Meta command in 
meta-analysis), random effects model was used to 
estimate the prevalence of smoking in the total 
general population in terms of gender. In 
addition, to minimize random scattering, point 
estimation of findings of all studies were 
calculated using adjusted analysis. Finally, meta-
regression method was used to study the effects 
of variables which were determined as probable 
causes of heterogeneity in studies. Point 
estimation of smoking prevalence level was 
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estimated in forest plots, in which square size 
showed that the weight of every study and lines 
on both sides indicate confidence interval of 95% 
(Figures 1 and 2). 
 
  
Figure 1. Difference between the estimated prevalence of smoking among men in each individual study 
and overall  
This chart shows that the range in prevalence of smoking among men is 13.1-32.25% (based on Bayes analysis) 
 
 
Figure 2. Difference between the estimated prevalence of smoking among women in each individual 
study and overall  
This chart shows that the range in prevalence of smoking among women is 0.7-8.9% (based on Bayes analysis) 
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Results 
In this study, findings of 17 individual studies 
(Figure 3 and table 1) and a 5-year review of the 
risk factor of non-communicable disease 
surveillance system in 30 provinces of Iran were 
used according to search strategies.9,16-31 It should 
be mentioned that 3 individual articles were 
published from results of the risk factor of  
non-communicable disease surveillance system; in 
order to prevent republication they were 
excluded.  
Total sample volume of primary studies was 
65588 (29036 men, and 34642 women). 
Nonconformity between total sample size and 
sample size in terms of gender is due to total 
sample volume has been reported only in two 
studies (Table 1). 
Smoking was defined only in 6 studies; age 
group of subjects were determined in 88.2% of 
studies (in most cases, it was more than 15 years 
of age, except for two cases in which age was 
higher than 12 years). Average cigarette smoked 
by smokers was between 11 and 16.8 cigarettes a 
day (Table 1). 
Of 17 individual studies, 1 (Ebadi, 2011) was 
carried out in all provinces of Iran and the 
remaining 16 were conducted in only 9 provinces 
(Tehran, Kerman, Isfahan, Ahvaz, Mazandaran, 
Khorasan Razavi, Shiraz, Semnan, and Bandar 
Abbas). 35.3% of the studies have been published 
since 2009 (Table 1). 
Total prevalence of smoking in studies which 
were entered into this meta-analysis varied from 
6.9% in a study by Estaji et al. (sample volume: 
1570 subjects; age group: 15-65; city: Sabzevar; 
smoking criterion was not mentioned) to 30% in a 
study by Soori (sample volume: 1600 subjects; age 
group: 18-84; city: Ahvaz; smoking criterion was 
not mentioned).18,28 Total estimation of smoking 
prevalence in this meta-analysis is 13.9%  
(10.2-17.6) based on random effect model (due to 
the presence of heterogeneity between studies  
P = 0.0001, Q = 2745.8) (Table 1). 
In 11 studies which reported smoking 
prevalence in men, smoking prevalence varied 
from 12.3% in a study carried out by Moghimbeigi 
et al. (sample volume: 809 men out of 1745 
subjects; age group: 15-20; area: north of Iran; 
smoking criterion was not mentioned) to 38.5% in 
a study by Esmaeili-Nadim and Ahmadi (sample 
volume: 247 men out of 391 subjects; age group:  
over 20; city: Rafsanjan; at least one cigarette a 
day during a year).29 In this meta-analysis, 
smoking prevalence in Iranian men was 21.7% 
(19.1-24.1) based on random effect model; due to 
the presence of heterogeneity between studies 
(Table 1).  
In 12 studies which reported smoking 
prevalence in women, smoking prevalence varied 
from 0.6% in a study carried out by Aryanpur et 
al.19 (sample volume: 342 women out of 684 
subjects; age group was not mentioned; city: 
Tehran; more than 100 cigarettes a day) to 9.8% in a 
study by Esmaeili-Nadim and Ahmadi (sample 
volume: 144 men out of 391 subjects; age group: 
over 20; city: Rafsanjan; at least one cigarette a day 
during a year).29 In this meta-analysis, smoking 
prevalence in Iranian women was 3.6% (2.4-4.7) 
based on random effect model; due to the presence 
of heterogeneity between studies (Table 1).  
Using meta-regression single-variable analysis, 
variables which caused heterogeneity (publication 
year and quality evaluation score) entered the 
model. However, the effect of these factors was 
not significant statistically (P > 0.05). After 
reviewing irrelevant studies and excluding them, 
meta-analysis was done again; in this case, Q level 
(heterogeneity) was reduced but not removed 
completely. Considering table 1 and by reviewing 
studies, it can be said theoretically that lack of 
using the same criterion to describe smoking is 
one of the most important probable reasons of 
heterogeneity.  
In the first step of reviewing of risk factors of 
non-communicable disease surveillance system, 
which was done for five periods (2004, 2006, 2007, 
2008, and 2009) on a national level in all provinces 
of Iran, results of 148 studies (considering results 
of every province in every step an independent 
finding) entered this meta-analysis. In these 
studies, 209404 Iranian subjects (50.2% men and 
49.8% women, aged 15-64) who lived in cities and 
villages were studied; population distribution was 
equal in terms of gender and 5 age groups (15-24, 
25-34, 35-44, 45-54, and 55-64). 
Based on the results of the first step of risk 
factors of non-communicable disease surveillance 
system, the prevalence of smoking in Iranian men 
in 148 studies, carried out in five years, varied 
from 10.78% in Ilam (2009) to 32.4% in Hamadan 
(2007).13 In this meta-analysis, total prevalence of 
smoking in men was 19.8% (19.01-20.7) (Table 2). 
Moreover, its prevalence among men aged 15-24 
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Figure 3. Search and analysis flowchart for selection of individual studies 
Total number of papers 
resulted from primary 
search in electronic 
databases (16664) 
Magiran (495) 
Google Scholar (15000) 
Iranmedex (343) 
Medlib (138) 
PubMed (91) 
SID (281)
Irandoc (313) 
Emro (3)
Relatively relevant 
papers (710) 
Eliminated studies after 
limiting search (15954) 
Papers deleted due to irrelevancy 
to study subject after evaluation 
of titles and abstracts (564) 
Potential subject relevant 
papers (146) 
Papers entered into the study 
for text appraisal (41) 
Deleted duplicated papers 
accessed from different data 
bases (105) 
Papers entered into the 
study for checking 
inclusion and exclusion 
criteria (23) 
Deleted papers after text 
appraisal (18) 
Relevant papers the 
information of which were 
entered into the meta-analysis 
process (17) 
Papers deleted after 
checking inclusion and 
exclusion criteria (9) 
Papers entered into the study 
through references check (3) 
Meta-analysis of Smoking Prevalence Moosazadeh et al. 
 
 
146 Addict Health, Summer & Autumn 2013; Vol 5, No 3-4 
 
http://ahj.kmu.ac.ir,    7 October 
 
 
Table 1. Description of the individual studies included in the meta-analysis and the pooled estimate of the prevalence of smoking 
Reference 
Year of 
Publica
tion 
Province 
Sample size Prevalence Criteria based on the 
prevalence smoking 
Age 
group 
(year) 
Average number of 
cigarettes per day Score Male Female Total Male Female Total 
Fotouhi et al.16 2009 Tehran 1794 2771 4565 20.6 2.9 11.9 >100 cigarettes per day > 15 11.6 12 
Ebadi et al.17 2011 Total of Iran 13619 14045 27664 - - 25.4 Indeterminate 18-65 - 11 
Emami et al.9 2001 Tehran 5023 6778 11801 22.0 2.1 10.6 At least one cigarette a day > 15 - 12 
Estaji et al.18 2006 Sabzevar 741 829 1570 - - 6.9 Indeterminate 18-65 - 10 
Aryanpur et al.19 2009 Tehran 342 342 684 19.9 0.6 10.2 Daily consumption of cigarettes - - 10 
Nouri et al.20 2004 Tehran 615 958 1573 23.5 1.8 9.7 Indeterminate 25-64 15.0 11 
Eftekhar Ardebili et al.21 2007 Tehran 1177 1528 2705 22.8 7.4 14.1 Indeterminate > 15 - 11 
Boskabady et al.22 2011 Mashhad 999 436 1435 17.2 2.5 12.7 Indeterminate > 10 - 10 
Rashidipour et al.23 2010 Semnan - 2104 2104 - 9.5 9.5 At least smoke a cigarette per day 30-70 - 8 
Aghamollaei and Zare24 2008 Bandar Abbas 912 898 1810 22.7 0.9 11.7 Indeterminate > 15 14.7 10 
Ziaadini and Ziaadini25 2006 Kerman 847 823 1670 - - 7.3 Indeterminate > 12 11.0 10 
Ahmadi et al.26 2001 Shiraz 782 553 1335 26.2 3.6 16.8 Indeterminate 16-90 13.4 10 
Meysamie et al.27 2004 Babol - - 310 - - 17.2 Indeterminate - 16.8 8 
Soori28 2003 Ahvaz - - 1600 - - 30.0 Indeterminate 18-84 - 9 
Esmaeili-Nadim and 
Ahmadi29 2004 Rafsanjan 247 144 391 38.5 9.8 24.2 
At least one cigarette a 
day for one Yr > 20 12.1 9 
Moghimbeigi et al.30 2009 North western provinces 809 936 1745 12.3 4.9 10.2 Indeterminate 15-20 - 9 
Sarraf-Zadegan et al.31 2004 Isfahan 1129 1497 2626 18.3 1.3 8.8 
At the time of the 
survey smoked 
cigarettes every day 
≥ 19 - 12 
Pooled estimate - - 29036 34642 65588 21.7  (19.1-24.1)
3.6  
(2.4-4.7) 
13.9  
(10.2-17.6) - - - - 
Heterogeneity 
(Random) - - - - - 
Q = 123.9 
P = 0.001 
Q = 264.5
P = 0.001
Q = 2745.8
P = 0.001 - - - - 
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Table 2. The pooled estimate of the prevalence of smoking among 15- to 64-year-old Iranian people [based on 
the study data of surveillance system of non-communicable diseases (NCD)-risk factor in 2004-2009] 
Gender Sample size Pooled estimate (random effect) % Q (Heterogeneity) P 
Male 105082 19.80 (19.01-20.7) 1258.5 0.001 
Female 104322 0.94 (0.80-1.1) 1230.0 0.001 
 
varied from 0% (Hormozgan, 2006) to 16.0%  
(Ilam, 2006); for men aged 25-34 it varied from 
10% (Ilam, 2007) to 42.4% (Hamadan, 2008); for 
men aged 35-44 it varied from 14.7% (Ilam, 2006) 
to 55.1% (Hamadan, 2007); for men aged 45-54 it 
varied from 11.6% (Sistan and Balouchestan, 2004) 
to 57.3% (Hamadan, 2007); and for men aged  
55-64 it varied from 9.9% (Boushehr, 2008) to 
67.9% (Markazi, 2004).13 According to results of 
this meta-analysis, total prevalence of smoking in 
men in age groups 15-24, 25-34, 35-44, 45-54, and 
55-64 were 5.2%, 22.9%, 32.9%, 31.9%, and 25.4%, 
respectively. 
Prevalence of smoking in Iranian women in 
studies carried out in five years on risk factors of 
non-communicable disease surveillance system 
varied from 0% in Ilam (2008) to 17.9% in Sistan 
and Balouchestan, (2004); in this meta-analysis, 
total prevalence of smoking in women was 0.94% 
(0.8-1.1) (Table 2). It was shown in 114 results of 
risk factors of non-communicable disease 
surveillance system that prevalence of smoking 
was 0% among women aged 15-24. In other 
studies, its prevalence varied from 0.3% (Zanjan, 
2004) to 6.2% (Isfahan, 2004). 97 studies reported 
that smoking prevalence was 0% in women aged 
25-34; in other results, it varied from 0.3% (Qom, 
2004) to 19.1% (Isfahan, 2004). In 59 cases of 
results, its prevalence was 0% in women aged  
35-44, while other studies showed that its 
prevalence fluctuated between 0.4% (Sistan and 
Balouchestan, 2004) and 20.8% (Isfahan, 2004).13 In 
37 studies, smoking prevalence was reported 0% 
for age group 44-55, while it was between 0.4% 
(Qom, 2004) and 30.7% (Markazi, 2004) in other 
studies. Finally, 32 studies revealed that smoking 
prevalence was 0% in women aged 55-64, while 
others reported that it varied from 0.9% (Esfahan, 
2006) to 35.4% (Markazi, 2004). According to 
results of this meta-analysis, total prevalence of 
smoking in women in age groups 15-24, 25-34,  
35-44, 45-54, and 55-64 was 0.23%, 0.50%, 1.03%, 
1.80%, and 2.30%, respectively.  
Publication year was entered into this meta- 
regression model as a probable cause of 
heterogeneity. There was a reverse relationship 
between smoking prevalence and publication year 
in both men and women. In various studies 
carried out on men, this variable was insignificant 
in causing heterogeneity of smoking prevalence, 
while it was significant in studies on women. The 
results of assessing the source of heterogeneity for 
men were coefficient = -0.2, P = 0.300, and for 
women were coefficient = -0.4, and P = 0.001). 
Discussion 
Results of the present meta-analysis showed that a 
great part of the general population over 15 years 
of age smoke every day. Almost all studies carried 
out in this regard have shown that smoking 
prevalence is completely different among men 
and women. According to this meta-analysis, 
smoking prevalence in men is 6.02 times more 
than that in women. However, a completely clear 
trend has not been observed in studies during the 
recent decade. It should be noted that smoking 
prevalence in men increases drastically after the 
age of 25, while it plummets after the age of 45. In 
women, however, there is a direct relationship 
between age and smoking and the maximum 
smoking prevalence is found in ages 55-65. 
In spite of the high prevalence of smoking in 
adults in Iran, this estimation is less than the 
results found in countries like Malaysia, 
Singapore, Australia, China, Egypt, and Italy. 
However, it is more than the results of Saudi 
Arabia and Oman; and is similar to Pakistan 
(Table 3).32-40 In an article extracted from findings 
of surveillance system of risk factors of non-
communicable diseases in 2004, smoking 
prevalence was 15.3% in 15-64 year olds; this is 
higher than the results of this research.27 By 
reviewing various provinces and regions of Iran, 
different levels of prevalence can be found. In a 
study by Emami et al. (Tehran), 10.6% of studied 
adults were active smokers.9 In a study carried 
out in Tehran on 4565 participants, the prevalence 
of smoking was 11.9% (10.6-13.3).16Ebadi et al. 
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reported that smoking prevalence was 25.4% in 
18-65 year olds.17 In another study, smoking 
prevalence in Tehran was 14.1%.21 11.7% of study 
subjects smoked in Bandar Abbas (people over 15 
years of age), and 12.7% in Mashhad; most results 
match the results of this meta-analysis.22,41 
Based on the meta-analysis of individual 
studies and meta-analysis of studies of the 
healthcare system, results of smoking prevalence 
in men were 21.7% (19.1-24.1) and 19.8%  
(19.01-20.7), respectively. These figures are similar 
to the findings of studies by Sarraf-Zadegan 
et al.,31Fotouhi et al.,16Boskabady et al.,22 and 
Ahmadi et al.26 In this research, smoking 
prevalence in the age group of 15-24 was less than 
the results of other studies (America: 43.7%; 
Brazil: 14.7%; Malaysia: 29.7%); this difference is a 
result of sociocultural factors.42 
The highest prevalence was found in the age 
groups of 35-44 and 45-54. Figure 4 shows that 
differences observed in these two groups are not 
meaningful, but the prevalence of smoking in 
these two groups is statistically more significant 
than other groups. According to figure 4, smoking 
prevalence increases in age groups 15-24 to 35-44 
and decreases in higher age groups; most studies 
confirm this trend.16 Significant and meaningful 
differences between 25-34 and 15-24 year olds can 
be attributed to some factors like financial 
independence in older people, less control of their 
family over them, and their involvement in social 
networks. Decreased prevalence in higher ages 
can be a result of some factors including 
prevalence of diseases related to smoking, 
understanding the dangers of smoking, and 
higher mortality in this age group. 
Based on the meta-analysis of individual 
studies and meta-analysis of studies of the 
healthcare system, results of smoking prevalence 
in women were 3.6% (2.4-4.7) and 0.94% (0.8-1.1), 
respectively. Significant and meaningful 
differences were observed in these two meta-
analyses. Studies of the healthcare system focused 
on smoking prevalence and other risk factors, and 
there were many questions which focused on 
different topics rather than one. Therefore, 
participants answered the questions less carefully 
and some of them did not answer them. It was 
observed in this meta-analysis that smoking 
prevalence increased as women got older. The 
highest frequency was observed in women aged 
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55-64. Differences between prevalence of smoking 
in various age groups were meaningful in regards 
to the confidence interval determined for these 
levels (Figure 5). Different levels of prevalence 
have been reported in individual studies 
conducted in various parts of Iran by Fotouhi 
et al.,16 Rashidipour,23Mehrabi et al.,43Ahmadi et 
al.,26 and Boskabady et al.;22 some of them are in 
accordance with the results of this meta-
analysisand some are not. Some of these studies 
were carried out in remote areas and their 
description of smoking was the main reason for  
this lack of agreement between the results.  
Smoking prevalence among women in other 
countries must also be taken into consideration. 
Findings in table 3 show that smoking prevalence 
is different in women of different countries. 
According to this meta-analysis, smoking 
prevalence in women in Iran is higher than in 
Egypt, Kuwait, Saudi Arabia, and Oman, is 
similar to Singapore, Malaysia, and China, and is 
less than Italy, America, and Australia. 
Among various age groups, smoking 
prevalence in men is significantly higher than that 
 
 
Figure 4. The pooled estimate of the prevalence of Smoking in men in different age groups and their 95% confidence 
interval [based on the study data of surveillance system of non-communicable diseases (NCD)-risk factors] 
 
 
Figure 5. The pooled estimate of the prevalence of Smoking in women in different age groups and their 95% 
confidence intervals [based on the study data of non-communicable diseases (NCD)-risk factors] 
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in women. This is in accordance with studies 
carried out both in Iran and in other Islamic and 
traditional countries which have a similar culture 
to Iran (Table 3). In these cultures, differences 
among men and women are due to the fact that 
smoking is considered bad and unacceptable for 
women and that is why they mainly do not report 
their smoking habits.  
Smoking pattern is influenced by different 
factors such as individual factors like age, sex, 
education, socioeconomic level, and social 
development.11In their study, Ebadi et al. showed 
that smoking prevalence increased by 2% for 
every unit of increase in age, while it decreases by 
5% for every unit of increase in education. In 
regard to sex, men smoke 5 times more than 
women. Employees smoke 1.4 times more than 
retired employees and 2 times less than 
unemployed people. Concerning marriage, 
divorced people smoke more. These factors must 
be taken into consideration in various programs. 
One of the main limitations of the present 
meta-analysis was related to the nature of the 
research, i.e. it was a secondary research and it 
was not possible to understand the agreement 
between the results of the primary studies. 
Moreover, heterogeneity was another restriction. 
It was not possible to recognize the sources of 
this heterogeneity, but it could be due to the 
difference in the criteria of different researchers 
in describing smoking, differences among 
interviewers and participants, filling the 
questionnaires according to their viewpoints, 
and differences in time, place and conditions of 
questions. 
Concerning different methodologies used in 
individual studies, it is recommended that a  
standard methodology be proposed for sampling 
method, study tools, and study method and a 
study be carried out periodically at a national level 
so as to provide a more comprehensive viewpoint 
in this regard. It is also suggested that more 
comprehensive programs and activities be 
implemented in all areas of Iran with regards to 
controlling narcotics including public and political 
supports, increased social pressures on inhibiting 
smoking, systematic education to understand risks 
of narcotics, and to make tobacco cessation 
programs a fundamental expectation and demand 
in society, and availability of effective cigarette-
quitting interferences (counseling and medical 
therapy) with the aim of decreasing smoking 
prevalence among adults and decreasing the 
burden on public health by diseases related to 
smoking. 
Conclusion 
According to the results of the present meta-
analysis, one fifth of Iranian men and 2-3% of 
women have daily smoking habits. This pattern 
increases dramatically from the age of 30 and is 
similar to the pattern in Islamic countries in the 
eastern Mediterranean region. It is clear that 
smoking must be considered a serious risk factor 
in every society due to its confirmed effects on 
smokers and their relatives as passive smokers.  
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  ﺷﻴﻮع ﻣﺼﺮف ﺳﻴﮕﺎر در ﺟﻤﻌﻴﺖ اﻳﺮان ﻣﺘﺎآﻧﺎﻟﻴﺰ
  
  ،3ﻋﻠﻲ ﻣﻴﺮزازادهدﻛﺘﺮ ، 2ﺣﺴﻦ ﺿﻴﺎءاﻟﺪﻳﻨﻲدﻛﺘﺮ ، 1زاده ﻲﻣﻮﺳ ﻣﺤﻤﻮددﻛﺘﺮ 
  5دوﺳﺖ ﻋﻠﻲ اﻛﺒﺮ ﺣﻖدﻛﺘﺮ  ،4ﻋﺴﮕﺮآﺑﺎداﺣﺪ اﺷﺮﻓﻲ 
  
  
  
  ﭼﻜﻴﺪه
ﺑﻨﺎﺑﺮاﻳﻦ در اﻳﻦ ﺗﺤﻘﻴﻖ ﺑﻪ ﻣﻨﻈﻮر ﻓﺮاﻫﻢ ﻧﻤﻮدن اﻃﻼﻋﺎت ﻣﻨﺎﺳﺐ . ﻣﺴﺘﻨﺪات زﻳﺎدي در ﺧﺼﻮص ﺷﻴﻮع ﻣﺼﺮف ﺳﻴﮕﺎر در اﻳﺮان وﺟﻮد دارد :ﻣﻘﺪﻣﻪ
  .ﺑﺮآورد ﺷﺪ در اﻳﺮان ﺼﺮف ﺳﻴﮕﺎرﮔﺬاري و ﺑﺎ ﻣﺘﺎآﻧﺎﻟﻴﺰ ﻧﺘﺎﻳﺞ ﺗﺤﻘﻴﻘﺎت ﻣﻮﺟﻮد، ﺷﻴﻮع ﻣ ﮔﻴﺮي و ﺳﻴﺎﺳﺖ ﺟﻬﺖ ﻋﺮﺻﻪ ﺗﺼﻤﻴﻢ
در « enitociNو  occaboT، gnikomS ،etteragiC»ﻫﺎي  ﻛﻠﻴﺪ واژهروش ﻣﻄﺎﻟﻌﻪ ﺣﺎﺿﺮ ﻣﺮور ﻣﺴﺘﻨﺪات ﺑﻮد ﻛﻪ ﺑﺎ ﺟﺴﺘﺠﻮي اﻟﻜﺘﺮوﻧﻴﻜﻲ  :ﻫﺎ روش
ﻣﻨﺎﺑﻊ ﻏﻴﺮ اﻟﻜﺘﺮوﻧﻴﻜﻲ، ﻧﺴﺒﺖ ﺑﻪ ﻫﺎي اﻃﻼﻋﺎﺗﻲ ﻓﺎرﺳﻲ و ﻫﻤﭽﻨﻴﻦ  ﻫﺎ در ﭘﺎﻳﮕﺎه ﻫﺎي اﻃﻼﻋﺎﺗﻲ اﻧﮕﻠﻴﺴﻲ و ﺟﺴﺘﺠﻮي ﻣﻌﺎدل ﻓﺎرﺳﻲ اﻳﻦ واژه ﭘﺎﻳﮕﺎه
ﻣﻄﺎﻟﻌﺎت داراي ﻣﻌﻴﺎرﻫﺎي ورود . ﺑﺎ ﺑﺮرﺳﻲ و ﻣﻄﺎﻟﻌﻪ ﻋﻨﺎوﻳﻦ و ﻣﺘﻦ ﻣﺴﺘﻨﺪات، ﻣﻮارد ﺗﻜﺮاري و ﻏﻴﺮ ﻣﺮﺗﺒﻂ ﺣﺬف ﮔﺮدﻳﺪ. درﻳﺎﻓﺖ اﻃﻼﻋﺎت اﻗﺪام ﺷﺪ
ﺑﺮاي ﺑﺮآورد ﺷﻴﻮع ﻛﻠﻲ ﺳﻴﮕﺎر اﺳﺘﻔﺎده ﻲ از ﻣﺪل اﺛﺮ ﺗﺼﺎدﻓﻲ ﺘﻴﻫﺘﺮوژﻧﺑﺮ اﺳﺎس ﻧﺘﺎﻳﺞ . ﺷﺪﻧﺪ 11ﻧﺴﺨﻪ  atatSاﻓﺰار  ﺟﻬﺖ اﻧﺠﺎم ﻣﺘﺎآﻧﺎﻟﻴﺰ وارد ﻧﺮم
  .ﮔﺮدﻳﺪ
در ﺑﻴﻦ . ﻣﻮرد ﺑﺮرﺳﻲ ﻗﺮار ﮔﺮﻓﺘﻨﺪاز ﻧﻈﺮ ﻣﺼﺮف روزاﻧﻪ ﺳﻴﮕﺎر ﺳﺎل  اﻳﺮاﻧﻲ ﺑﺰرگ 299472در ﻣﻄﺎﻟﻌﺎت اوﻟﻴﻪ و ﻧﻈﺎم ﻣﺮاﻗﺒﺖ ﻏﻴﺮ واﮔﻴﺮ،  :ﻫﺎ ﻳﺎﻓﺘﻪ
ﺳﻴﮕﺎر در ﻣﺮدان ﺑﺮ  ﻣﺼﺮف ﺷﻴﻮع. درﺻﺪ ﻣﺘﻐﻴﺮ ﺑﻮد 0/6-9/8درﺻﺪ و در زﻧﺎن از  21/3-83/5ﻣﻄﺎﻟﻌﺎت اوﻟﻴﻪ، داﻣﻨﻪ ﺷﻴﻮع ﻣﺼﺮف ﺳﻴﮕﺎر در ﻣﺮدان از 
 0/49و  3/6درﺻﺪ و در زﻧﺎن ﺑﻪ ﺗﺮﺗﻴﺐ  91/8و  12/7ﻫﺎي ﻏﻴﺮ واﮔﻴﺮ ﺑﻪ ﺗﺮﺗﻴﺐ  اﺳﺎس ﻣﺘﺎآﻧﺎﻟﻴﺰ ﻣﻄﺎﻟﻌﺎت اوﻟﻴﻪ و ﻧﻈﺎم ﻣﺮاﻗﺒﺖ ﻋﻮاﻣﻞ ﺧﻄﺮ ﺑﻴﻤﺎري
  .درﺻﺪ ﺗﺨﻤﻴﻦ زده ﺷﺪ 31/9ﺳﺎل ﺑﺮ اﺳﺎس ﻣﺘﺎآﻧﺎﻟﻴﺰ ﻣﻄﺎﻟﻌﺎت اوﻟﻴﻪ  ﺳﻴﮕﺎر در ﻛﻞ ﺟﻤﻌﻴﺖ ﺑﺰرگ ﻣﺼﺮف ﺷﻴﻮع ،ﻫﻤﭽﻨﻴﻦ. درﺻﺪ ﺑﺮآورد ﺷﺪ
. ﺳﺎل ﻣﺮدان اﻳﺮاﻧﻲ ﺳﻴﮕﺎري ﻫﺴﺘﻨﺪ ﺳﺎل و ﻳﻚ ﭘﻨﺠﻢ از ﺟﻤﻌﻴﺖ ﺑﺰرگ 51اي از ﻛﻞ ﺟﻤﻌﻴﺖ ﻋﻤﻮﻣﻲ ﺑﺎﻻي  ﺑﺨﺶ ﻗﺎﺑﻞ ﻣﻼﺣﻈﻪ :ﮔﻴﺮي ﻧﺘﻴﺠﻪ
ﮔﻴﺮي از راﻫﻜﺎرﻫﺎي ﻣﻨﺎﺳﺐ، ﺑﺎر  ﻫﺎ، در ﺻﻮرت ﻋﺪم ﺑﻬﺮه ﺑﺎ ﺗﻮﺟﻪ ﺑﻪ رواﺑﻂ ﻋﻠﻴﺘﻲ ﺛﺎﺑﺖ ﺷﺪه ﺑﻴﻦ ﻣﺼﺮف ﺳﻴﮕﺎر ﺑﺎ ﺑﺴﻴﺎري از ﺑﻴﻤﺎري ،ﺑﻨﺎﺑﺮاﻳﻦ
  .ﻫﺎي ﻣﺮﺗﺒﻂ ﺑﺎ اﻳﻦ ﻋﺎﻣﻞ در اﻳﺮان اﻓﺰاﻳﺶ ﺧﻮاﻫﺪ ﻳﺎﻓﺖ ﺑﻴﻤﺎري
  ﺳﻴﮕﺎر، ﺷﻴﻮع، اﻳﺮان، ﻣﺮور ﺳﺎﺧﺘﺎر ﻳﺎﻓﺘﻪ، ﻣﺘﺎآﻧﺎﻟﻴﺰ :واژﮔﺎن ﻛﻠﻴﺪي
 .ﺷﻴﻮع ﻣﺼﺮف ﺳﻴﮕﺎر در ﺟﻤﻌﻴﺖ اﻳﺮان ﻣﺘﺎآﻧﺎﻟﻴﺰ .دوﺳﺖ ﻋﻠﻲ اﻛﺒﺮ ، ﺿﻴﺎءاﻟﺪﻳﻨﻲ ﺣﺴﻦ، ﻣﻴﺮزازاده ﻋﻠﻲ، اﺷﺮﻓﻲ ﻋﺴﮕﺮآﺑﺎد اﺣﺪ، ﺣﻖﻣﺤﻤﻮد زاده ﻲﻣﻮﺳ :ارﺟﺎع
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 ﻣﺮوريﻣﻘﺎﻟﻪ
